Ampra Biobact Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth 3.20%
- Profit Growth -6.00%
- Ebitda -422.28%
- Net Worth 43.60%
- Total Assets 137.43%
About Ampra Biobact
Ampra Biobact Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 September 2011 and has a history of 13 years and four months. Its registered office is in Solapur, Maharashtra, India.
The Corporate was formerly known as Akash Crop Science Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Malsiddh Mugale and Mithun Mugale serve as directors at the Company.
Company Details
- Location
Solapur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15137PN2011PTC140692
- Company No.
140692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Ampra Biobact?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malsiddh Mugale  | Director | 08-Sep-2011 | Current |
| Mithun Mugale | Director | 19-Dec-2014 | Current |
Financial Performance of Ampra Biobact.
Ampra Biobact Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.2% increase. The company also saw a slight decrease in profitability, with a 6% decrease in profit. The company's net worth Soared by an impressive increase of 43.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ampra Biobact?
Unlock access to Ampra Biobact's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ampra Distilleries Private LimitedMalsiddh Mugale and Mithun Mugale are mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2023 | Axis Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Ampra Biobact?
Ampra Biobact has a workforce of 25 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ampra Biobact, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ampra Biobact's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
